Alev Ok Atılgan

2PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Dec 01, 2022
Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.

Alev Ok Atılgan, Özlem Özen, A Nihan Haberal Reyhan

|Apr 25, 2022
The Overexpression of Programmed Death-Ligand 2 in Uterine Adenosarcoma: Correlation with High-Grade Morphology, Mutant Type TP53 Expression and Clinical Outcomes.

Alev Ok Atılgan, Eda Yılmaz Akçay, Özlem Özen

Pageof 1

Frequent Collaborators